| [1] |
Warnakulasuriya S, Johnson NW, van der Waal I.Nomenclature and classification of potentially malignant disorders of the oral mucosa[J].J Oral Pathol Med, 2007, 36(10):575-580
|
| [2] |
Aghbari SMH, Abushouk AI, Attia A, et al.Malignant transformation of oral lichen planus and oral lichenoid lesions: A meta-analysis of 20095 patient data[J].Oral Oncol, 2017, 68:92-102
|
| [3] |
中华口腔医学会口腔黏膜病专业委员会.口腔扁平苔藓诊疗指南[J].中华口腔医学杂志, 2012, 47(7):399-401
|
| [4] |
Shou J, Jing J, Xie J, et al.Nuclear factor of activated T cells in cancer development and treatment[J].Cancer Lett, 2015, 361(2):174-184
|
| [5] |
Shin K, Lim A, Zhao C, et al.Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors[J].Cancer Cell, 2014, 26(4):521-533
|
| [6] |
Kawahara T, Kashiwagi E, Ide H, et al.Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1[J].Oncotarget, 2015, 6(3):1582-1593
|
| [7] |
Kawahara, Kashiwagi, Li Y, et al.Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis[J].Mol Carcinog, 2016, 55(2):161-169
|
| [8] |
Romano S, Mallardo M, Chiurazzi F, et al.The effect of FK506 on transforming growth factor signaling and apoptosis in chronic lymphocytic leukemia B cells[J].Haematologica, 2008, 93(7):1039-1048
|
| [9] |
李永文, 张洪兵, 李颖, 等.免疫抑制剂FK506对肺癌细胞增殖和迁移的作用研究[J].中国肺癌杂志, 2017, 20(7):446-451
|
| [10] |
Becker JC, Houben R, Vetter CS, et al.The carcinogenic potential of tacrolimus ointment beyond immune suppression-a hypothesis creating case report[J].BMC Cancer, 2006, 6:7-
|
| [11] |
Mattsson U, Magnusson B, Jontell M.Squamous cell carcinoma in a patient with oral lichen planus treated with topical application of tacrolimus[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010, 110(1):e19-e25
|
| [12] |
Morita M, Asoda S, Tsunoda K, et al.The onset risk of carcinoma in patients continuing tacrolimus[J].Odontology, 2017, 105(2):262-266
|
| [13] |
Ganong, WF.Review of Medical Physiology [M]. 22nd Edition. New York: McGraw-Hill Medical，2005
|
| [14] |
Viola JP, Carvalho LD, Fonseca BP, et al.NFAT transcription factors: from cell cycle to tumor development[J].Braz J Med Biol Res, 2005, 38(3):335-344
|
| [15] |
Kawahara T, Kashiwagi E, Ide H, et al.The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion[J].Prostate, 2015, 75(6):573-584
|
| [16] |
Lee JV, Berry CT, Kim K, et al.Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca2+-NFAT signaling[J].Genes Dev, 2018, 1(7/8):497-511
|
| [17] |
Pham LV, Tamayo AT, Yoshimura LC, et al.Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival[J].Blood, 2005, 106(12):3940-3947
|
| [18] |
Ishida R, Koyanagi-Aoi M, Oshima N, et al.The Tissue-Reconstructing Ability of Colon CSCs Is Enhanced by FK506 and Suppressed by GSK3 Inhibition[J].Mol Cancer Res, 2017, 15(10):1455-1466
|
| [19] |
Qin JJ, Wang W, Zhang R.Experimental Therapy of Advanced Breast Cancer: Targeting NFAT1-MDM2-p53 Pathway[J].Prog Mol Biol Transl Sci, 2017, 151:195-216
|
| [20] |
Shoshan E, Braeuer RR, Kamiya T, et al.NFAT1 Directly Regulates IL8 and MMP3 to Promote Melanoma Tumor Growth and Metastasis[J].Cancer Res, 2016, 76(11):3145-3155
|
| [21] |
Zhou ZH, Song JW, Li W, et al.The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis[J].J Exp Clin Cancer Res, 2017, 36(1):130-
|
| [22] |
Chen P, Shan Z, Zhao J, et al.NFAT1 promotes cell motility through MMP-3 in esophageal squamous cell carcinoma[J].Biomed Pharmacother, 2017, 86:541-546
|
| [23] |
Buchholz M, Schatz A, Wagner M, et al.Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway[J].EMBO J, 2006, 25(15):3714-3124
|
| [24] |
K?enig A, Linhart T, Schlengemann K, et al.NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells[J].Gastroenterology, 2010, 138(3):1189-1199
|
| [25] |
Shakhova I, Li Y, Yu F, et al.PPP3CB contributes to poor prognosis through activating nuclear factor of activated T-cells signaling in neuroblastoma[J].Mol Carcinog, 2019, 58(3):426-435
|
| [26] |
Gregory MA, Phang TL, Neviani P, et al.Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl[J].Cancer Cell, 2010, 18(1):74-87
|
| [27] |
Pham LV, Tamayo AT, Yoshimura LC, et al.Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival[J].Blood, 2005, 106(12):3940-3947
|
| [28] |
Pham LV, Tamayo AT, Li C, et al.An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas[J].Blood, 2010, 116(19):3899-3906
|
| [29] |
Fu L, Lin-Lee YC, Pham LV, et al.Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas[J].Blood, 2006, 107(11):4540-4548
|
| [30] |
M?rklin M, Heitmann JS, Fuchs AR, et al.NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia[J].Nat Commun, 2017, 8(1):755-
|
| [31] |
Xiao T, Zhu JJ, Huang S, et al.Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer[J].Oncogene, 2016, 36(20):2835-2845
|
| [32] |
Huang K, Kiefer C, Kamal A.Novel role for NFAT3 in ERK-mediated regulation of CXCR4[J].PLoS One, 2014, 9(12):e115249-
|
| [33] |
Zhang X, Kang T, Zhang L, et al.NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide[J].Oncotarget, 2017, 8(32):52735-52745
|
| [34] |
Ding W, Tong Y, Zhang X, et al.Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53[J].Sci Rep, 2016, 6:19793-
|
| [35] |
Zhao X, Liu J, Feng L, et al.Anti-angiogenic effects of Qingdu granule on breast cancer through inhibiting NFAT signaling pathway[J].J Ethnopharmacol, 2018, 222:261-269
|
| [36] |
Lee SH, Rigas NK, Lee CR, et al.Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma[J].Oncotarget, 2016, 7(28):43239-43255
|
| [37] |
Geil WM, Yen A.Nuclear Raf-1 kinase regulates the CXCR5 promoter by associating with NFATc3 to drive retinoic acid-induced leukemic cell differentiation[J].FEBS J, 2014, 281(4):1170-1180
|
| [38] |
Miyakawa AA, Gir?o-Silva T, Krieger JE, et al.Rapamycin activates TGF receptor independently of its ligand: implications for endothelial dysfunction[J].Clin Sci, 2018, 132(4):437-447
|
| [39] |
Romano S, Mallardo M, Chiurazzi F, et al.The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells[J].Haematologica, 2008, 93(7):1039-1048
|
| [40] |
Wowro SJ, Schmitt KRL, Tong G, et al.Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells[J].Int Immunopharmacol, 2016, 30:9-17
|
| [41] |
Zhu W, Li Z, Xiong L, et al.FKBP3 Promotes Proliferation of Non-Small Cell Lung Cancer Cells through Regulating Sp1/HDAC2/p27[J].Theranostics, 2017, 7(12):3078-3089
|
| [42] |
Ott M, Litzenburger UM, Rauschenbach KJ, et al.Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway[J].Glia, 2015, 63(1):78-90
|
| [43] |
Datta D, Contreras AG, Basu A, et al.Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells[J].Cancer Res, 2009, 69(23):8902-8909
|
| [44] |
Wang N, He T, Shen Y, et al.Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer[J].ACS Appl Mater Interfaces, 2016, 8(7):4368-4377
|
| [45] |
Garrido W, Mu?oz M, San Martín R, et al.FK506 confers chemosensitivity to anticancer drugs in glioblastoma multiforme cells by decreasing the expression of the multiple resistance-associated protein-1[J].Biochem Biophys Res Commun, 2011, 411(1):62-68
|
